These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19405507)
1. Concise synthesis of capuramycin. Kurosu M; Li K; Crick DC Org Lett; 2009 Jun; 11(11):2393-6. PubMed ID: 19405507 [TBL] [Abstract][Full Text] [Related]
2. Improved synthesis of capuramycin and its analogues. Wang Y; Siricilla S; Aleiwi BA; Kurosu M Chemistry; 2013 Oct; 19(41):13847-58. PubMed ID: 24014478 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors. Siricilla S; Mitachi K; Wan B; Franzblau SG; Kurosu M J Antibiot (Tokyo); 2015 Apr; 68(4):271-8. PubMed ID: 25269459 [TBL] [Abstract][Full Text] [Related]
4. Biosynthetic and Synthetic Strategies for Assembling Capuramycin-Type Antituberculosis Antibiotics. Biecker AL; Liu X; Thorson JS; Yang Z; Van Lanen SG Molecules; 2019 Jan; 24(3):. PubMed ID: 30691073 [No Abstract] [Full Text] [Related]
5. Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin. Hotoda H; Furukawa M; Daigo M; Murayama K; Kaneko M; Muramatsu Y; Ishii MM; Miyakoshi S; Takatsu T; Inukai M; Kakuta M; Abe T; Harasaki T; Fukuoka T; Utsui Y; Ohya S Bioorg Med Chem Lett; 2003 Sep; 13(17):2829-32. PubMed ID: 14611838 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds. Hotoda H; Daigo M; Furukawa M; Murayama K; Hasegawa CA; Kaneko M; Muramatsu Y; Ishii MM; Miyakoshi S; Takatsu T; Inukai M; Kakuta M; Abe T; Fukuoka T; Utsui Y; Ohya S Bioorg Med Chem Lett; 2003 Sep; 13(17):2833-6. PubMed ID: 14611839 [TBL] [Abstract][Full Text] [Related]
7. In vitro antimycobacterial activities of capuramycin analogues. Reddy VM; Einck L; Nacy CA Antimicrob Agents Chemother; 2008 Feb; 52(2):719-21. PubMed ID: 18070956 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of capuramycin and its analogues via a Ferrier-type I reaction and their biological evaluation. Kusaka S; Yamamoto K; Shinohara M; Minato Y; Ichikawa S Bioorg Med Chem; 2022 Nov; 73():117011. PubMed ID: 36191548 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives. Patel KN; Telvekar VN Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490 [TBL] [Abstract][Full Text] [Related]
10. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids. Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670 [TBL] [Abstract][Full Text] [Related]
11. A biocatalytic approach to capuramycin analogues by exploiting a substrate permissive N-transacylase CapW. Liu X; Jin Y; Cai W; Green KD; Goswami A; Garneau-Tsodikova S; Nonaka K; Baba S; Funabashi M; Yang Z; Van Lanen SG Org Biomol Chem; 2016 Apr; 14(16):3956-62. PubMed ID: 27050157 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of analogs of CPZEN-45, a novel antituberculosis drug. Ishizaki Y; Takahashi Y; Kimura T; Inoue M; Hayashi C; Igarashi M J Antibiot (Tokyo); 2019 Dec; 72(12):970-980. PubMed ID: 31471594 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents. Hirano S; Ichikawa S; Matsuda A Bioorg Med Chem; 2008 May; 16(9):5123-33. PubMed ID: 18375127 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives. Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497 [TBL] [Abstract][Full Text] [Related]
15. Studies on peptidyl nucleoside antibiotics: synthesis and antifungal evaluation of pyranosyl nucleoside analogs of nikkomycin. Stauffer CS; Fothergill AW; Rinaldi MG; Dutta A Future Med Chem; 2009 May; 1(2):379-89. PubMed ID: 21425974 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives. Gonçalves RS; Kaiser CR; Lourenço MC; de Souza MV; Wardell JL; Wardell SM; da Silva AD Eur J Med Chem; 2010 Dec; 45(12):6095-100. PubMed ID: 20932608 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents. Ali MA; Yar MS Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-tuberculosis activity of glycitylamines. Corkran HM; Dangerfield EM; Haslett GW; Stocker BL; Timmer MS Bioorg Med Chem; 2016 Feb; 24(4):693-702. PubMed ID: 26810833 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents. Trivedi AR; Dodiya DK; Dholariya BH; Kataria VB; Bhuva VR; Shah VH Bioorg Med Chem Lett; 2011 Sep; 21(18):5181-3. PubMed ID: 21824772 [TBL] [Abstract][Full Text] [Related]